Research Article
Open access
Published on 20 March 2025
Download pdf
Cao,J. (2025). Impact of Antidepressant Medication on Lactating Women and Infant Health. Theoretical and Natural Science,96,40-46.
Export citation

Impact of Antidepressant Medication on Lactating Women and Infant Health

Jiaming Cao *,1,
  • 1 Nanjing High School of Jiangsu Province, Jiangyin, 214400, China

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/2025.21607

Abstract

Around 10% of pregnant and postpartum women globally suffer from depression, with the incidence of postpartum depression ranging from 10% to 15%. Besides, about 50% to 80% of postpartum women exhibit varying degrees of depressive symptoms following childbirth. And epidemiological data demonstrate that the global prevalence of postpartum depression is 17.22% (95% confidence interval: 16.00-18.51). Despite the effectiveness of antidepressants in relieving depressive symptoms, their use in breastfeeding women may result in transfer via breast milk, potentially affecting infant health. Therefore, this paper presents a review of the safety of using antidepressants during breastfeeding, with a focus on the permeability of different antidepressants in breast milk and their potential risks to infants. The results indicate huge differences in the concentrations of various medications in breast milk, with some drugs exhibiting higher permeability, which may negatively impact infant health. As such, in clinical practice, healthcare professionals should carefully select an antidepressant treatment plan for breastfeeding women according to the pharmacokinetic properties of the drug and the physiological characteristics of the infant, so as to minimize potential risks to both maternal and infant health.

Keywords

Antidepressants, Breastfeeding Women, Postpartum Depression, Drug Transfer, Infant Health

[1]. Schoretsanitis, G., et al. (2021) Antidepressant transfer to amniotic fluid, cord blood, and breast milk: a systematic review and comprehensive analysis. Prog neuropsychopharmacology Biological psychiatry.

[2]. Weissman, A.M., et al. (2004) Pooled analysis of antidepressant levels in nursing mothers, breast milk and nursing infants. American Journal of Psychiatry, 161(6): 1066-1078.

[3]. Schoretsanitis, G., et al. (2020). Effects of pregnancy on antidepressant pharmacokinetics: a systematic critical review and meta-analysis. Expert Opin medication Metab Toxicol, 16(5): 431-440.

[4]. Deligiannidis, K.M., et al. (2023) Zuranolone for postpartum depression. American Journal of Psychiatry, 180(9) : 668-675.

[5]. WHO. (20013) WHO Recommendations on Postnatal Care of the Mother and Newborn. Geneva: World Health Organization.

[6]. Hale, T.W., et al. (2010) Discontinuation syndrome in newborns whose mothers took antidepressants while pregnant or breastfeeding. Breastfeed Med,5:283-288.

[7]. Payne, J.L. and Maguire, J. (2018) Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol, 52: 165-180.

[8]. Grzeskowiak, L., et al. (2022) Perinatal antidepressant use and breastfeeding outcomes: Findings from the Norwegian Mother, Father and Child Cohort Study. Acta Obstet Gynecol Scand, 101: 344-354.

[9]. Venkatesh, K., et al. (2017) Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: An observational cohort study. J Perinatol, 37: 1003-1009.

[10]. Hendrick, V., et al. (2001) Venlafaxine and breast-feeding. Am J Psychiatry.

[11]. Uguz, F. (2021) A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther, 28: e118-e126.

[12]. Desaunay, P., et al. (2023) Benefits and risks of antidepressants during pregnancy: a systematic review of a meta-analysis. Pediatric drugs, 25(3): 247-265.

[13]. Berle, J.Ø., et al. (2004) Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry. 65(9): 1228-1234.

[14]. Pons, G., Rey, E. and Matheson, I. (1994) Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations. Clin Pharmacokinet. 27(4): 270-289.

[15]. Kieviet, N., et al. (2015) Risk factors for poor neonatal adaptation after exposure to antidepressants in utero. Acta Paediatr, 104: 384-391.

[16]. Kronenfeld, N., et al. (2018) Chronic use of psychotropic medications in breastfeeding women: Is it safe? PLoS One, 13: e0197196.

Cite this article

Cao,J. (2025). Impact of Antidepressant Medication on Lactating Women and Infant Health. Theoretical and Natural Science,96,40-46.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science

Conference website: https://2025.icbiomed.org/
ISBN:978-1-83558-985-4(Print) / 978-1-83558-986-1(Online)
Conference date: 24 October 2025
Editor:Alan Wang
Series: Theoretical and Natural Science
Volume number: Vol.96
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).